In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxorubicin, Rubex, Adriamycin Drug Master File in Korea (Doxorubicin, Rubex, Adriamycin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxorubicin, Rubex, Adriamycin. The MFDS reviews the Doxorubicin, Rubex, Adriamycin KDMF as part of the drug registration process and uses the information provided in the Doxorubicin, Rubex, Adriamycin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxorubicin, Rubex, Adriamycin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxorubicin, Rubex, Adriamycin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxorubicin, Rubex, Adriamycin suppliers with KDMF on PharmaCompass.